These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34241796)

  • 41. [Genetic diagnosis of patients with primary agammaglobulinemia treated at third level peruvian centers].
    Matos-Benavides E; García-Gomero D; Inocente-Malpartida R; Córdova-Calderón W; Aldave-Becerra J
    Rev Peru Med Exp Salud Publica; 2019; 36(4):664-669. PubMed ID: 31967259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel BTK gene mutation creates a de-novo splice site in an X-linked agammaglobulinemia patient.
    Chear CT; Ripen AM; Mohamed SA; Dhaliwal JS
    Gene; 2015 Apr; 560(2):245-8. PubMed ID: 25680287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and genetic profiles of patients with X-linked agammaglobulinemia from southeast Turkey: Novel mutations in BTK gene.
    Doğruel D; Serbes M; Şaşihüseyinoğlu AŞ; Yılmaz M; Altıntaş DU; Bişgin A
    Allergol Immunopathol (Madr); 2019; 47(1):24-31. PubMed ID: 30072168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report.
    Li M; Chen W; Sun X; Wang Z; Zou X; Wei H; Wang Z; Chen W
    BMC Med Genet; 2019 Sep; 20(1):157. PubMed ID: 31510946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cohort of Iranian Patients with Congenital Agammaglobulinemia: Mutation Analysis and Novel Gene Defects.
    Abolhassani H; Vitali M; Lougaris V; Giliani S; Parvaneh N; Parvaneh L; Mirminachi B; Cheraghi T; Khazaei H; Mahdaviani SA; Kiaei F; Tavakolinia N; Mohammadi J; Negahdari B; Rezaei N; Hammarstrom L; Plebani A; Aghamohammadi A
    Expert Rev Clin Immunol; 2016; 12(4):479-86. PubMed ID: 26910880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
    Vihinen M; Brandau O; Brandén LJ; Kwan SP; Lappalainen I; Lester T; Noordzij JG; Ochs HD; Ollila J; Pienaar SM; Riikonen P; Saha BK; Smith CI
    Nucleic Acids Res; 1998 Jan; 26(1):242-7. PubMed ID: 9399844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
    Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
    Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of rare splice-site Bruton's tyrosine kinase mutation with atypical X-linked agammaglobulinemia.
    Park SE; Neaves BI; Adams K
    Ann Allergy Asthma Immunol; 2023 Mar; 130(3):364-365. PubMed ID: 36509410
    [No Abstract]   [Full Text] [Related]  

  • 50. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia.
    de Weers M; Brouns GS; Hinshelwood S; Kinnon C; Schuurman RK; Hendriks RW; Borst J
    J Biol Chem; 1994 Sep; 269(39):23857-60. PubMed ID: 7929028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia.
    Gray DH; Villegas I; Long J; Santos J; Keir A; Abele A; Kuo CY; Kohn DB
    CRISPR J; 2021 Apr; 4(2):191-206. PubMed ID: 33876953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia.
    Conley ME; Howard V
    J Pediatr; 2002 Oct; 141(4):566-71. PubMed ID: 12378199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency.
    Ponsford MJ; Shillitoe BMJ; Humphreys IR; Gennery AR; Jolles S
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):525-534. PubMed ID: 34596095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. X linked agammaglobulinaemia with a 'leaky' phenotype.
    Jones A; Bradley L; Alterman L; Tarlow M; Thompson R; Kinnon C; Morgan G
    Arch Dis Child; 1996 Jun; 74(6):548-9. PubMed ID: 8758136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
    Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
    Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
    J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia.
    Hoshino A; Okuno Y; Migita M; Ban H; Yang X; Kiyokawa N; Adachi Y; Kojima S; Ohara O; Kanegane H
    J Clin Immunol; 2015 Feb; 35(2):108-11. PubMed ID: 25591849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital.
    Chun JK; Lee TJ; Song JW; Linton JA; Kim DS
    Yonsei Med J; 2008 Feb; 49(1):28-36. PubMed ID: 18306466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Widely divergent clinical phenotype of x-linked agammaglobulinemia in two cousins].
    Jansen AG; Noordzij JG; Bröcker-Vriends AH; van Dongen JJ; van Tol MJ; Bredius RG
    Ned Tijdschr Geneeskd; 2004 May; 148(21):1053-6. PubMed ID: 15185441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management.
    Pashangzadeh S; Yazdani R; Nazari F; Azizi G; Abolhassani H; Aghamohammadi A
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1434-1447. PubMed ID: 32384040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.